title: Atenolol: a promising alternative to propranolol for the treatment of hemangiomas.
authors.affiliation: Department of Pediatric Hematology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands.
authors.forename: Martine F
authors.initials: MF
authors.lastname: Raphaël
authors.affiliation: Department of Pediatric Dermatology & Allergology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands. Electronic address: m.degraaf-10@umcutrecht.nl.
authors.forename: Marlies
authors.initials: M
authors.lastname: de Graaf
authors.affiliation: Department of Pediatric Plastic Surgery, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands.
authors.forename: Corstiaan C
authors.initials: CC
authors.lastname: Breugem
authors.affiliation: Department of Pediatric Dermatology & Allergology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands.
authors.forename: Suzanne G M A
authors.initials: SGMA
authors.lastname: Pasmans
authors.affiliation: Department of Pediatric Cardiology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands.
authors.forename: Johannes M P J
authors.initials: JMPJ
authors.lastname: Breur
mesh_terms: D001262:Atenolol / Q000009:adverse effects / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006391:Hemangioma / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D008297:Male; D011433:Propranolol / Q000009:adverse effects* / Q000627:therapeutic use; D018570:Risk Assessment; D012878:Skin Neoplasms / Q000175:diagnosis / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D001262:Atenolol; D011433:Propranolol